乳房切除至最终再造的时间对生活质量的影响及相关因素
本研究分析前瞻性登记数据库中2010-2015年接受乳房再造且Breast-Q随访≥12个月的患者,排除乳房切除当日完成最终再造者。198例女性中,最终再造中位时间199天;BMI≥35 kg/m²者间隔最长936天(p=0.001),自体再造较假体或脂肪移植延迟更长325天(p=0.02),延迟再造者平均1269天(p<0.001)。线性回归显示最终再造每延迟一天,Breast-Q各领域评分均降低。
要点
- 最终再造中位时间199天,BMI≥35 kg/m²者间隔最长936天。
- 自体再造较假体或脂肪移植延迟更长325天,但校正模型中不成立。
- 延迟再造者等待最长平均1269天,每延迟一天QoL各领域均降低。
核心结论
- 乳房切除至最终再造的较长间隔可能与生活质量结局下降相关。
- 乳房切除类型、再造类型和患者人口学特征可能影响该间隔,讨论再造方案时值得考虑。
研究设计与样本
- 分析本机构前瞻性收集的乳房再造登记数据库。
- 纳入2010-2015年接受乳房再造、Breast-Q随访至少12个月且最终再造时间可获取的患者。
- 排除乳房切除当日完成最终乳房再造的患者。
- 共识别198例女性患者。
主要发现
- 最终再造中位时间为199天。
- BMI≥35 kg/m²的女性经历最长间隔936天(p=0.001)。
- 非洲裔美国女性延迟更长(均值527天;p=0.05)。
- 自体再造者较假体再造或脂肪移植延迟显著更长325天(p=0.02),但校正模型中不成立。
- 与分期再造相比,延迟再造者等待最长(均值1269天;p<0.001)。
临床怎么用
- 讨论再造方案时值得考虑乳房切除类型、再造类型和患者人口学特征对最终再造间隔的影响。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast cancer patients often undergo prolonged periods of care due to chemotherapy, radiation, and multiple breast reconstruction procedures. The time to final reconstruction (TTFR) after mastectomy can span years, during which time patients may experience reduced quality of life (QoL). However, the relationship between prolonging this interval and long-term QoL is unclear. METHODS: We analyzed a prospectively collected registry of patients who received breast reconstruction at our institution. We obtained data for patients meeting the following criteria: received breast reconstruction between 2010 and 2015; had at least 12 months of Breast-Q follow-up; and for whom TTFR was available. Patients who received final breast reconstruction on the same day as mastectomy were excluded. RESULTS: We identified 198 female patients. The median time to final reconstruction was 199 days. Women with a BMI of ≥35 kg/m2 experienced the longest interval (936 days; p=0.001). African-American women also experienced greater delays (mean: 527 days; p=0.05). Women undergoing autologous reconstruction experienced a significantly greater delay compared to implant-based or fat grafting (325 days; p=0.02). However, this did not hold in the adjusted model. Compared to staged, women undergoing delayed reconstruction waited the longest (mean: 1269 days; p<0.001). Regarding QoL, a linear regression revealed reductions across all domains per each day of delay in final reconstruction. CONCLUSION: A longer interval between mastectomy and final reconstruction may be associated with decreases in QoL outcomes. Factors including mastectomy type, reconstruction type, and patient demographics may impact this interval. These factors are worth considering when discussing reconstruction options.
引用
- Jaffry U, Bienert C, Foster DG, et al. Time to final breast reconstruction: Effect on quality of life and associated factors. J Plast Reconstr Aesthet Surg. 2025. PMID: 40440985. doi:10.1016/j.bjps.2025.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。